• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在埃塞俄比亚人中,黄嘌呤氧化酶活性受环境因素影响。

Xanthine oxidase activity is influenced by environmental factors in Ethiopians.

作者信息

Aklillu Eleni, Carrillo Juan Antonio, Makonnen Eyasu, Bertilsson Leif, Ingelman-Sundberg Magnus

机构信息

Division of Molecular Toxicology, IMM, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

出版信息

Eur J Clin Pharmacol. 2003 Oct;59(7):533-6. doi: 10.1007/s00228-003-0653-8. Epub 2003 Aug 21.

DOI:10.1007/s00228-003-0653-8
PMID:12937875
Abstract

OBJECTIVES

To investigate xanthine oxidase (XO) polymorphism in Ethiopians and influence of environmental factors, smoking habit and gender-related differences on enzyme activity among Ethiopians living in Ethiopia or Sweden.

METHODS

One hundred healthy unrelated Ethiopians living in Ethiopia and 73 living in Sweden participated in the study. Subjects received a 100-mg oral dose of caffeine before bedtime. All urine voided in the following 8 h was collected and the concentrations of 1-methyluracil (1U) and 1-methylxanthine (1X) micromol/l) were analyzed by means of high-performance liquid chromatography. The 1U/(1X+1U) metabolic ratio (MR) was calculated and used as an index of XO activity.

RESULTS

XO activity was not normally distributed ( P<0.0001; Shapiro-Wilk's test). The incidence of putative XO poor metabolizers in Ethiopians was 4%. The effect of differences in country of residence, gender and smoking habit was analyzed using three-way ANOVA/MANOVA. The post-hoc test ( P<0.05) and Kruskal-Wallis ANOVA ( P<0.004), median test showed a significant difference in XO activity among Ethiopians living in Ethiopia compared with those living in Sweden, the activity being higher in Ethiopians living in Ethiopia. The 95% CI for differences between the two means was (0.012; 0.044). No significant difference was observed in XO MR between men and women or between smokers and non-smokers, the 95% CI for the differences being (-0.059; 0.037) and (-0.010; 0.016) respectively.

CONCLUSION

The XO activity is polymorphic in Ethiopians. Neither gender nor smoking-related differences influenced XO activity but the difference in activity between Ethiopians living in Sweden or in Ethiopia indicates influence of other environmental factors such as dietary habits on XO activity.

摘要

目的

研究埃塞俄比亚人的黄嘌呤氧化酶(XO)多态性,以及环境因素、吸烟习惯和性别差异对生活在埃塞俄比亚或瑞典的埃塞俄比亚人酶活性的影响。

方法

100名居住在埃塞俄比亚的健康无亲属关系的埃塞俄比亚人和73名居住在瑞典的埃塞俄比亚人参与了该研究。受试者在睡前口服100毫克咖啡因。收集接下来8小时内排出的所有尿液,并通过高效液相色谱法分析1-甲基尿嘧啶(1U)和1-甲基黄嘌呤(1X,微摩尔/升)的浓度。计算1U/(1X + 1U)代谢率(MR)并用作XO活性指标。

结果

XO活性不呈正态分布(P < 0.0001;Shapiro-Wilk检验)。埃塞俄比亚人中推定的XO代谢不良者发生率为4%。使用三因素方差分析/多变量方差分析分析居住国家、性别和吸烟习惯差异的影响。事后检验(P < 0.05)和Kruskal-Wallis方差分析(P < 0.004)、中位数检验显示,与居住在瑞典的埃塞俄比亚人相比,居住在埃塞俄比亚的埃塞俄比亚人在XO活性方面存在显著差异,居住在埃塞俄比亚的埃塞俄比亚人活性更高。两种平均值之间差异的95%置信区间为(0.012;0.044)。男性与女性之间或吸烟者与非吸烟者之间的XO MR未观察到显著差异,差异的95%置信区间分别为(-0.059;0.037)和(-0.010;0.016)。

结论

埃塞俄比亚人的XO活性具有多态性。性别和吸烟相关差异均未影响XO活性,但居住在瑞典或埃塞俄比亚的埃塞俄比亚人之间的活性差异表明饮食习惯等其他环境因素对XO活性有影响。

相似文献

1
Xanthine oxidase activity is influenced by environmental factors in Ethiopians.在埃塞俄比亚人中,黄嘌呤氧化酶活性受环境因素影响。
Eur J Clin Pharmacol. 2003 Oct;59(7):533-6. doi: 10.1007/s00228-003-0653-8. Epub 2003 Aug 21.
2
N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.N-乙酰转移酶-2(NAT2)表型受埃塞俄比亚人基因型与环境相互作用的影响。
Eur J Clin Pharmacol. 2018 Jul;74(7):903-911. doi: 10.1007/s00228-018-2448-y. Epub 2018 Mar 27.
3
Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden.通过对生活在埃塞俄比亚或瑞典的埃塞俄比亚人进行表型分析和基因分型所证明的环境对CYP2D6催化的异喹胍羟基化影响的证据。
Pharmacogenetics. 2002 Jul;12(5):375-83. doi: 10.1097/00008571-200207000-00005.
4
In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population.在塞尔维亚人群中进行 CYP2A6 和黄嘌呤氧化酶酶活性的体内评估。
Eur J Clin Pharmacol. 2010 Jun;66(6):571-8. doi: 10.1007/s00228-010-0785-6. Epub 2010 Feb 13.
5
Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?用咖啡因对N-乙酰基转移酶2型和黄嘌呤氧化酶进行表型分析:应何时采集尿液样本?
Eur J Clin Pharmacol. 2009 Apr;65(4):411-7. doi: 10.1007/s00228-008-0597-0. Epub 2008 Dec 13.
6
In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.通过反相高效液相色谱法监测咖啡因代谢率对希腊人群样本中CYP1A2、CYP2A6、NAT-2和黄嘌呤氧化酶活性进行体内评估。
Biomed Chromatogr. 2007 Feb;21(2):190-200. doi: 10.1002/bmc.736.
7
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.N-乙酰转移酶、黄嘌呤氧化酶和CYP1A2活性的种族及性别差异。
Clin Pharmacol Ther. 1992 Dec;52(6):643-58. doi: 10.1038/clpt.1992.203.
8
Distribution of xanthine oxidase activity in a Nigerian population.
Eur J Clin Pharmacol. 2015 Jun;71(6):687-690. doi: 10.1007/s00228-015-1852-9. Epub 2015 May 5.
9
[Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].[用于评估N-乙酰转移酶、CYP1A2和黄嘌呤氧化酶活性的咖啡因代谢物测定]
Yao Xue Xue Bao. 1997 Nov;32(11):813-8.
10
Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.通过反相高效液相色谱法分析尿中咖啡因代谢物以评估生物转化酶活性。
J Chromatogr B Biomed Sci Appl. 1998 May 8;709(1):27-34. doi: 10.1016/s0378-4347(98)00016-4.

引用本文的文献

1
Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular Disease.基于药物遗传学对黄嘌呤脱氢酶在心血管疾病中进行治疗性开发的潜在机会。
Antioxidants (Basel). 2024 Nov 22;13(12):1439. doi: 10.3390/antiox13121439.
2
Disordered Glucose Levels Are Associated with Xanthine Oxidase Activity in Overweight Type 2 Diabetic Women.超重 2 型糖尿病女性的葡萄糖水平紊乱与黄嘌呤氧化酶活性有关。
Int J Mol Sci. 2022 Sep 23;23(19):11177. doi: 10.3390/ijms231911177.
3
Evaluation of vanillin as a probe drug for aldehyde oxidase and phenotyping for its activity in a Western Indian Cohort.

本文引用的文献

1
Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.埃塞俄比亚人CYP1A2的基因多态性影响诱导和表达:内含子1中具有单核苷酸多态性的新型单倍型的特征分析
Mol Pharmacol. 2003 Sep;64(3):659-69. doi: 10.1124/mol.64.3.659.
2
Allopurinol protects enterocytes from hypoxia-induced apoptosis in vivo.别嘌醇在体内可保护肠上皮细胞免受缺氧诱导的凋亡。
J Trauma. 2002 Sep;53(3):415-20; discussion 420-1. doi: 10.1097/00005373-200209000-00003.
3
A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test.
香草醛作为醛氧化酶探针药物的评价及其在印度西部队列中活性表型分析。
Indian J Pharmacol. 2021 May-Jun;53(3):213-220. doi: 10.4103/ijp.IJP_463_18.
4
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?药物代谢和转运体遗传学如何为精神药物处方提供信息?
Front Genet. 2020 Dec 8;11:491895. doi: 10.3389/fgene.2020.491895. eCollection 2020.
5
Determination of Urinary Caffeine Metabolites as Biomarkers for Drug Metabolic Enzyme Activities.测定尿中咖啡因代谢物作为药物代谢酶活性的生物标志物。
Nutrients. 2019 Aug 19;11(8):1947. doi: 10.3390/nu11081947.
6
N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.N-乙酰转移酶-2(NAT2)表型受埃塞俄比亚人基因型与环境相互作用的影响。
Eur J Clin Pharmacol. 2018 Jul;74(7):903-911. doi: 10.1007/s00228-018-2448-y. Epub 2018 Mar 27.
7
Serum and aqueous xanthine oxidase levels, and mRNA expression in anterior lens epithelial cells in pseudoexfoliation.假性剥脱综合征中血清和房水黄嘌呤氧化酶水平以及晶状体前囊上皮细胞中的mRNA表达。
Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1161-7. doi: 10.1007/s00417-015-3043-x. Epub 2015 May 10.
8
Distribution of xanthine oxidase activity in a Nigerian population.
Eur J Clin Pharmacol. 2015 Jun;71(6):687-690. doi: 10.1007/s00228-015-1852-9. Epub 2015 May 5.
9
High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population.通过咖啡因试验测得的高CYP2A6酶活性以及埃塞俄比亚人群中CYP2A6变异等位基因的独特分布。
OMICS. 2014 Jul;18(7):446-53. doi: 10.1089/omi.2013.0140. Epub 2013 Dec 31.
10
In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population.在塞尔维亚人群中进行 CYP2A6 和黄嘌呤氧化酶酶活性的体内评估。
Eur J Clin Pharmacol. 2010 Jun;66(6):571-8. doi: 10.1007/s00228-010-0785-6. Epub 2010 Feb 13.
一项在日本九州进行的利用咖啡因试验对三种药物代谢酶进行的群体表型研究。
Clin Pharmacol Ther. 2002 Aug;72(2):200-8. doi: 10.1067/mcp.2002.126173.
4
Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden.通过对生活在埃塞俄比亚或瑞典的埃塞俄比亚人进行表型分析和基因分型所证明的环境对CYP2D6催化的异喹胍羟基化影响的证据。
Pharmacogenetics. 2002 Jul;12(5):375-83. doi: 10.1097/00008571-200207000-00005.
5
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.别嘌醇抑制黄嘌呤氧化酶对慢性心力衰竭高尿酸血症患者内皮功能和外周血流的影响:两项安慰剂对照研究的结果
Circulation. 2002 Jun 4;105(22):2619-24. doi: 10.1161/01.cir.0000017502.58595.ed.
6
Xanthine oxidase activation in mild gestational hypertension.轻度妊娠期高血压中黄嘌呤氧化酶的激活
Hypertens Pregnancy. 2002;21(1):1-11. doi: 10.1081/PRG-120002905.
7
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy.别嘌醇可改善特发性扩张型心肌病患者的心肌效能。
Circulation. 2001 Nov 13;104(20):2407-11. doi: 10.1161/hc4501.098928.
8
Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system.黄嘌呤氧化还原酶系统的细胞分布、代谢及调控
Chem Biol Interact. 2000 Dec 1;129(1-2):195-208. doi: 10.1016/s0009-2797(00)00203-9.
9
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".采用“库珀斯敦鸡尾酒”对细胞色素P450 1A2、细胞色素P450 2C19、细胞色素P450 2D6、细胞色素P450 3A、N-乙酰基转移酶-2和黄嘌呤氧化酶进行联合表型评估。
Clin Pharmacol Ther. 2000 Oct;68(4):375-83. doi: 10.1067/mcp.2000.109519.
10
Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine.利用血浆、唾液和尿液检测评估咖啡因作为CYP1A2体内探针的情况。
Ther Drug Monit. 2000 Aug;22(4):409-17. doi: 10.1097/00007691-200008000-00008.